TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$0.27
-0.01 (-1.96%)
As of Feb 8, 2:17 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 26.00M 22.93M 28.87M
Net Income -3,802,417 -3,978,629 -3,915,216
EPS
Profit Margin -14.6% -17.4% -13.6%
Rev Growth +20.6% +0.2% +12.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.20M 6.25M 6.38M
Total Equity 22.67M 21.99M 21.09M
D/E Ratio 0.27 0.28 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -5,256,206 -4,739,765 -5,087,055
Free Cash Flow -3,224,852 -2,115,724 -2,331,954